Items tagged with Diagnostics
FDA: New data shows test can help physicians remove patients with suspected TB from isolation earlier (post)
The FDA today (February 12) cleared the Cepheid Xpert MTB/RIF Assay to help physicians determine if patients with suspected tuberculosis (TB) can be removed from airborne infection isolation. This expanded use allows healthcare providers to use one or two negative Xpert MTB/RIF Assay test results to help them determine whether a patient showing signs and symptoms of pulmonary TB should continue to be kept in a hospital airborne isolation room.
Latent TB prevalence in China may be overestimated (post)
Researchers from the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing have found tuberculin skin testing may be overestimating the prevalence of latent tuberculosis in China.
Ancon Medical NBT detects tuberculosis biomarkers (post)
Blookmington, MN, February 20, 2015 -- Medical device company Ancon Medical Inc. has confirmed today that it has detected Tuberclosis biomarkers using its revolutionary new breath screening technology NBT-GC that makes it possible to easily find the indicators for deadly and dangerous diseases such as TB at their earliest stages. The potential benefits of the Nanoparticle Biomarker Tagging (NBT) technology are far ranging, from conducting mass screenings for contagious diseases, to identifying Lung Cancer and Tuberculosis.
Simple swab test holds promise to ease tuberculosis detection (post)
Drawing inspiration from veterinary medicine, researchers at the University of Washington have helped developed a new prospective approach to detect tuberculosis (TB) – easy-to-obtain oral swab samples, greatly improving on standard diagnostics.
Stop TB Partnership initiative reveals surprising results - 1 in 9 staff tested positive for latent TB infection (post)
Dear colleagues, partners and stakeholders,
Innovations in tuberculosis diagnostics: Progress and translational challenges (post)
This article reviews the current best diagnostic tools available for TB diagnosis and monitoring, and describes the most important gaps, and translational challenges for developing innovative products that can meet the needs.
Latent TB: a time bomb among people living with HIV in Kenya (post)
World TB Day (24 March) highlights the need to reach, treat and cure everyone who has the disease. So why are people living with HIV in Kenya, who could also have latent tuberculosis, not offered effective diagnostic tests which mean they can receive early treatment?
South Africa: More than 40,000 prisoners screened for MDR-TB (post)
More than 40,000 prisoners have been screened for multidrug-resistant tuberculosis (MDR-TB) this year as government attempts to tackle TB in correctional facilities.
Page 7 of 69 · Total posts: 0
←First 6 7 8 Last→